Age
Age Range
Mean |
30-73
43 |
Nuclear Grade
Grade-I
Grade-II
Grade-III
No Data |
10(50%)
7(35%)
2(10%)
1(5%) |
Lymph Node Positive
0
1-3
4-9
Above 10 |
7(36.84%)
6 (31.5%)
4(21.05%)
2 (10.5%) |
Hormonal Status
ER+/PR+
ER-/PR-
ER+/PR- |
8(40%)
11(55%)
1(5%) |
Her-2 Status
Her-2 Positive
Her-2 Negative |
10(50%)
10(50%) |
Menopausal Status
Postmenopausal
Premenopausal |
13(65%)
7(35%) |
Chemotherapy
Adriyamycine, 5FU, Endoxane |
20(100%) |